# Twice-Yearly Eczema Shots Maintain 85% Clearance, Data Show

- slug: twice-yearly-eczema-shots-maintain-85-clearance-data-show
- date: 2026-03-23
- category: Biotech & Life Sciences

Two Injections a Year: Apogee's Eczema Drug Posts Durability Data That Could Reshape the Dupixent Era

Apogee Therapeutics released 52-week maintenance data for zumilokibart, its anti-IL-13 antibody for moderate-to-severe atopic dermatitis.

---